Concerns arise in Chinese bid for genomics firm

The pending sale of a major American gene-mapping company to a Chinese firm is sparking yet another dust-up over what sensitive industries the rising Asian power ought to be allowed to dominate in the United States.

A key question — as it has been with Chinese involvement in aviation, cloud computing and telecom hardware — is whether there are national security concerns attached to allowing a company largely funded by the Chinese government to have access to human DNA being decoded for doctors, researchers and pharmaceutical companies.

View the original article here: Concerns arise in Chinese bid for genomics firm

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}
screenshot at  pm

Are pesticide residues on food something to worry about?

In 1962, Rachel Carson’s Silent Spring drew attention to pesticides and their possible dangers to humans, birds, mammals and the ...
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.